Jaundice in pregnancy--1976.
An integrative survey is given of three disease processes, in which recent progress of a fundamental nature has been made, primarily affecting the liver, either coincident with or caused by the gravid state. The three conditions considered include (1) recurrent cholestasis of pregnancy (RCP), (2) viral hepatitis coincident with pregnancy, and (3) acute fatty liver of pregnancy (AFLP). In addition to an assessment of our present knowledge with respect to RCP and AFLP, new genetic hypotheses are proposed. In the latter, the proposal of an ornithine transcarbamylase deficiency, similar to that seen in Reye's syndrome, has potential therapeutic implications that are explored. In light of the currently available information on the interaction between maternal viral hepatitis and the variant forms of vertical maternal-fetal transmission, tentative recommendations regarding management of the newborn are suggested.
D045930:Anabolic Agents / Q000009:adverse effects; D000818:Animals; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002779:Cholestasis / Q000139:chemically induced / Q000209:etiology; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects; D045166:Estradiol Congeners / Q000009:adverse effects; D004997:Ethinyl Estradiol / Q000502:physiology; D005234:Fatty Liver / Q000209:etiology; D005260:Female; D006506:Hepatitis A / Q000635:transmission; D006509:Hepatitis B / Q000635:transmission; D006801:Humans; D007565:Jaundice / Q000209:etiology* / Q000503:physiopathology; D008099:Liver / Q000187:drug effects / Q000503:physiopathology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000503:physiopathology*; D011251:Pregnancy Complications, Infectious; D045167:Progesterone Congeners / Q000009:adverse effects; D012008:Recurrence; D012202:Reye Syndrome / Q000473:pathology
D045930:Anabolic Agents; D003280:Contraceptives, Oral, Synthetic; D045166:Estradiol Congeners; D045167:Progesterone Congeners; D004997:Ethinyl Estradiol